Insider Selling: Alignment Healthcare (NASDAQ:ALHC) President Sells $482,700.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $16.09, for a total value of $482,700.00. Following the completion of the sale, the president directly owned 998,813 shares of the company’s stock, valued at approximately $16,070,901.17. The trade was a 2.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, April 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.87, for a total value of $626,100.00.
• On Wednesday, March 18th, Dawn Christine Maroney sold 36,749 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.84, for a total value of $655,602.16.
• On Monday, March 16th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.48, for a total value of $524,400.00.
• On Thursday, March 12th, Dawn Christine Maroney sold 29,113 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.45, for a total value of $508,021.85.

Alignment Healthcare Trading Down 1.7%

NASDAQ ALHC opened at $16.37 on Friday. The company has a market cap of $3.38 billion, a PE ratio of 181.89, a PEG ratio of 2.33 and a beta of 1.26. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.56. Alignment Healthcare, Inc. has a 12 month low of $11.63 and a 12 month high of $23.87. The stock has a 50 day moving average of $18.87 and a 200-day moving average of $19.43.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.01 by $0.04. The company had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The firm’s revenue for the quarter was up 33.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.05) EPS. On average, equities research analysts anticipate that Alignment Healthcare, Inc. will post 0.19 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently weighed in on ALHC. Barclays increased their price target on Alignment Healthcare from $18.00 to $19.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. KeyCorp restated an “overweight” rating and issued a $28.00 price target on shares of Alignment Healthcare in a research note on Thursday, January 22nd. Robert W. Baird set a $28.00 price target on Alignment Healthcare in a research note on Friday, January 30th. Raymond James Financial set a $22.00 price target on Alignment Healthcare in a research note on Thursday, May 7th. Finally, Wall Street Zen upgraded Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Two research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Alignment Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $24.60.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of ALHC. Wellington Management Group LLP increased its position in shares of Alignment Healthcare by 167.3% in the third quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock worth $193,516,000 after purchasing an additional 6,940,277 shares during the period. Bank of New York Mellon Corp boosted its stake in Alignment Healthcare by 232.5% in the first quarter. Bank of New York Mellon Corp now owns 3,313,110 shares of the company’s stock valued at $58,377,000 after buying an additional 2,316,777 shares in the last quarter. Invesco Ltd. boosted its stake in Alignment Healthcare by 122.3% in the second quarter. Invesco Ltd. now owns 4,170,529 shares of the company’s stock valued at $58,387,000 after buying an additional 2,294,739 shares in the last quarter. Capital World Investors acquired a new stake in Alignment Healthcare in the fourth quarter valued at about $44,203,000. Finally, Loomis Sayles & Co. L P acquired a new stake in Alignment Healthcare in the fourth quarter valued at about $44,162,000. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.